SkinBioTherapeutics to begin human study this month

3rd Sep 2018 15:23

(Sharecast News) - Life science company SkinBioTherapeutics updated the market on its stability testing on Monday, reporting that the stability criteria required for its human study had been met.The AIM-traded firm said it now expected to begin the study in September, as planned."Demonstrating the extended stability of the cream formulation was a key step to commencing the human study," said chief executive officer Dr Cath O'Neill."This remains on track to start this month."

Top Risers

Share	Price	Change
GCM Resources (GCM)	4.00	29.03%
Oxford Biodyn (OBD)	0.14	16.67%
Pci-pal (PCIP)	51.00	15.91%
Essentra (ESNT)	109.40	13.37%
Empresaria Group (EMR)	25.00	11.11%

Top Fallers

Share	Price	Change
AB Dynamics (ABDP)	808.00	-24.2%
Abrdn Property (API)	1.60	-12.33%
Headlam (HEAD)	5.20	-10.34%
ECR Minerals (ECR)	0.185	-9.76%
Immupharma (IMM)	3.90	-9.3%

Top By Volume

Share	Price	Volume
Premier African Minerals (PREM)	0.0175	571,295,894
Forgent (FORG)	0.0135	116,120,955
ECR Minerals (ECR)	0.185	30,999,893
Lloyds (LLOY)	113.90	30,611,888
Oracle Power (ORCP)	0.0425	28,177,878

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.